TRANSFORMATION CAPITAL — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Aktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times.
AI & Machine LearningEnterprise SoftwareSales TechSan Francisco, US
David J. Ehrlich(Executive Officer, Director)Derek Choy(Executive Officer, Director)Jin Huang(Executive Officer)Rob Willson(Executive Officer)Marc-david Cohen(Executive Officer)
BoardAnthony Glenning(Director)
Board seatJared Kesselheim· per SEC Form D
Co-investorsHLM Venture PartnersNorwest Venture PartnersStarfish VenturesUpfront VenturesB4 Capital
HQC Holdings, renamed Health Catalyst in 2017, supplies data and analytics software and services to healthcare organizations.
Salt Lake City, US
Jeffrey P. Selander(Executive Officer)Brent Dover(Executive Officer)Daniel D. Burton(Executive Officer, Director)
BoardPromod Haque(Director)
Board seatTodd CozzensMichael Dixon· per SEC Form D · $50M raise · filed Sep 2020
Co-investorsSorenson Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.